Jefferies Group LLC Arvinas, Inc. Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$60.27 - $81.57 $435,209 - $589,016
-7,221 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$65.85 - $96.21 $475,502 - $694,732
7,221 New
7,221 $286,000
Q4 2019

Feb 13, 2020
SELL
$15.39 - $44.38 $156,762 - $452,054
-10,186 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$21.55 - $27.61 $219,508 - $281,235
10,186 New
10,186 $220,000

Others Institutions Holding ARVN

# of Institutions
224
Shares Held
68.7M
Call Options Held
166K
Put Options Held
31.3K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.32B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email